X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (307) 307
Magazine Article (31) 31
Publication (24) 24
Newspaper Article (22) 22
Patent (19) 19
Conference Proceeding (5) 5
Book / eBook (2) 2
Book Chapter (2) 2
Book Review (1) 1
Dissertation (1) 1
Paper (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (65) 65
index medicus (62) 62
female (45) 45
male (45) 45
medicine & public health (23) 23
adult (20) 20
animals (20) 20
children (20) 20
research (20) 20
middle aged (18) 18
pediatrics (17) 17
management (15) 15
aged (14) 14
double-blind method (14) 14
drug therapy (14) 14
treatment outcome (14) 14
adolescent (13) 13
psychiatry (13) 13
analysis (12) 12
atomoxetine hydrochloride (12) 12
attention deficit hyperactivity disorder (12) 12
entomology (12) 12
attention deficit disorder with hyperactivity - drug therapy (11) 11
clinical trials (11) 11
double-blind (11) 11
care and treatment (10) 10
child (10) 10
infant (10) 10
medicine (10) 10
usage (10) 10
adhd (9) 9
atomoxetine (9) 9
attention-deficit hyperactivity disorder (9) 9
diagnosis (9) 9
propylamines - therapeutic use (9) 9
adrenergic uptake inhibitors - therapeutic use (8) 8
article (8) 8
attention-deficit/hyperactivity disorder (8) 8
behavior (8) 8
internal medicine (8) 8
mice (8) 8
oncology (8) 8
orthopedics (8) 8
acute disease (7) 7
aged, 80 and over (7) 7
allergie (7) 7
child, preschool (7) 7
deficit hyperactivity disorder (7) 7
general practice / family medicine (7) 7
health aspects (7) 7
patients (7) 7
surface (7) 7
surgery (7) 7
titanium (7) 7
traumatic surgery (7) 7
abridged index medicus (6) 6
allergy (6) 6
asthma (6) 6
cancer (6) 6
contamination (6) 6
immunology (6) 6
medicine, general & internal (6) 6
natural history (6) 6
neurosciences (6) 6
performing operations (6) 6
pharmacology & pharmacy (6) 6
psychology, developmental (6) 6
respiratory system (6) 6
review (6) 6
sports medicine (6) 6
studies (6) 6
surgical orthopedics (6) 6
therapy (6) 6
transporting (6) 6
adults (5) 5
biomedicine (5) 5
bone cement (5) 5
clinical neurology (5) 5
comorbidity (5) 5
condensed matter - mesoscale and nanoscale physics (5) 5
data processing (5) 5
disease models, animal (5) 5
emergency medicine (5) 5
emergency service, hospital (5) 5
fixed constructions (5) 5
hematology (5) 5
hospitalization (5) 5
impact (5) 5
infants (5) 5
materials science, multidisciplinary (5) 5
methods (5) 5
methylphenidate (5) 5
multidisciplinary sciences (5) 5
new species (5) 5
performance (5) 5
risk factors (5) 5
severity of illness index (5) 5
symptoms (5) 5
time factors (5) 5
united states (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychopharmacology, ISSN 0033-3158, 3/2013, Volume 226, Issue 2, pp. 189 - 200
Treatment of attention-deficit/hyperactivity disorder (ADHD) has for many years relied on psychostimulants, particularly various formulations of amphetamines... 
ADHD | Neurosciences | Biomedicine | Pharmacology/Toxicology | Atomoxetine (Strattera®) | Abuse potential | Psychiatry | Nonstimulant | EXTRACELLULAR DOPAMINE | SUBSTANCE USE DISORDERS | C-FOS | RHESUS-MONKEYS | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | PHARMACOLOGICAL CHARACTERIZATION | DOPAMINE TRANSPORTER | NEUROSCIENCES | PREFRONTAL CORTEX | DISCRIMINATIVE-STIMULUS | Atomoxetine (Strattera (R)) | ALCOHOL-USE DISORDERS | PHARMACOLOGY & PHARMACY | Adrenergic Uptake Inhibitors - adverse effects | Adrenergic Uptake Inhibitors - therapeutic use | Humans | Norepinephrine Plasma Membrane Transport Proteins - antagonists & inhibitors | Attention Deficit Disorder with Hyperactivity - drug therapy | Behavior, Addictive - metabolism | Substance-Related Disorders - physiopathology | Drug-Seeking Behavior - drug effects | Animals | Propylamines - therapeutic use | Atomoxetine Hydrochloride | Adrenergic Uptake Inhibitors - pharmacology | Propylamines - pharmacology | Receptors, Neurotransmitter - metabolism | Propylamines - adverse effects | Protein Binding - physiology | Drug therapy | Attention-deficit hyperactivity disorder | Psychotropic drugs | Drug abuse | Attention Deficit Hyperactivity Disorder | Psychopharmacology | Drug discrimination | Self-administration | Attention deficit hyperactivity disorder | Central nervous system | Clinical trials | Electrophysiology | Data processing | Norepinephrine transporter | Amphetamine | Microdialysis | Reviews | Stimulants | gamma -Aminobutyric acid A receptors | Reinforcement | Dopamine transporter | Locomotor activity | Methylphenidate | Review
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2009, Volume 48, Issue 12, pp. 1165 - 1172
Abstract Objective Understanding placebo response is a prerequisite to improving clinical trial methodology. Data from placebo-controlled trials of atomoxetine... 
Pediatrics | Psychiatry | response | attention-deficit/hyperactivity disorder | placebo | ADHD | DEPRESSION | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | ONCE-DAILY ATOMOXETINE | ADULTS | ACTIVE-CONTROL TRIALS | CHILDREN | ADOLESCENTS | DOUBLE-BLIND | OROS METHYLPHENIDATE | PEDIATRICS | EXTENDED-RELEASE | Outcomes of Treatment | Stimulants | Attention Deficit Hyperactivity Disorder | Prediction | Drug Therapy | Data Analysis | Children | Adolescents | Science Education | Patients | Rating Scales | Humans | Anxiety Disorders - diagnosis | Male | Multicenter Studies as Topic | Atomoxetine Hydrochloride | Female | Anxiety Disorders - drug therapy | Attention Deficit Disorder with Hyperactivity - diagnosis | Child | Depressive Disorder, Major - drug therapy | Adrenergic Uptake Inhibitors - adverse effects | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Comorbidity | Placebo Effect | Personality Assessment | Anxiety Disorders - psychology | Attention Deficit Disorder with Hyperactivity - drug therapy | Randomized Controlled Trials as Topic | Depressive Disorder, Major - psychology | Propylamines - therapeutic use | Adolescent | Attention Deficit Disorder with Hyperactivity - psychology | Depressive Disorder, Major - diagnosis | Research Design | Propylamines - adverse effects | Demographic aspects | Drug therapy | Placebo effect | Attention-deficit hyperactivity disorder | Clinical trials | Ethnicity | Children & youth
Journal Article
Spine, ISSN 0362-2436, 04/2009, Volume 34, Issue 7, pp. 648 - 654
Study Design. The authors investigated gait abnormalities and mechanical hypersensitivity associated with invertebral disc herniation in a rat model of... 
Herniation | Gait | Interleukins | Pathophysiology | Intervertebral disc | Nucleus pulposus | Radiculopathy | SELECTIVE-INHIBITION | INTERVERTEBRAL DISCS | intervertebral disc | NERVE-CONDUCTION-VELOCITY | herniation | radiculopathy | NECROSIS-FACTOR-ALPHA | DORSAL-ROOT GANGLION | LUMBAR RADICULOPATHY | CLINICAL NEUROLOGY | interleukins | EXPERIMENTAL DISC HERNIATION | gait | nucleus pulposus | pathophysiology | HISTOLOGIC-CHANGES | TNF-ALPHA | ORTHOPEDICS | SPINAL NERVE | Autoimmune Diseases - physiopathology | Autoantibodies - metabolism | Autoantigens - metabolism | Intervertebral Disc - physiopathology | Cytokines - analysis | Male | Ganglia, Spinal - physiopathology | Intervertebral Disc Displacement - immunology | Inflammation - blood | Fibrocartilage - physiopathology | Intervertebral Disc - immunology | Radiculopathy - pathology | Inflammation Mediators - metabolism | Radiculopathy - physiopathology | Intervertebral Disc - pathology | Autoimmune Diseases - pathology | Intervertebral Disc Displacement - physiopathology | Cytokines - blood | Disease Models, Animal | Fibrocartilage - pathology | Ganglia, Spinal - immunology | Autoimmune Diseases - immunology | Intervertebral Disc Displacement - pathology | Rats | Inflammation - immunology | Lameness, Animal - pathology | Transplantation, Autologous - methods | Rats, Sprague-Dawley | Lameness, Animal - physiopathology | Hyperalgesia - physiopathology | Hyperalgesia - immunology | Animals | Ganglia, Spinal - pathology | Lameness, Animal - etiology | Lumbar Vertebrae - pathology | Fibrocartilage - immunology | Radiculopathy - immunology | Inflammation - physiopathology
Journal Article
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1176-6328, 2013, Volume 9, pp. 815 - 822
Journal Article
Patient Preference and Adherence, ISSN 1177-889X, 2011, Volume 5, pp. 547 - 554
Background: The aim of this study was to assess the reasons for discontinuing or continuing olanzapine in patients with schizophrenia, from the perspectives of... 
Schizophrenia | Antipsychotic agents | Olanzapine | Questionnaires | questionnaires | olanzapine | MEDICINE, GENERAL & INTERNAL | ANTIPSYCHOTICS | INTERVIEW | PREDICTORS | SYMPTOMS | schizophrenia | antipsychotic agents | ASSOCIATION | CONTINUATION
Journal Article
The Forensic Examiner, ISSN 1084-5569, 03/2012, Volume 21, Issue 1, p. 34
Journal Article
LANCET ONCOLOGY, ISSN 1470-2045, 12/2010, Volume 11, Issue 12, pp. 1127 - 1134
Background Evidence supports a reduction in mortality from breast cancer with mammographic screening in the general population of women aged 40-49 years but... 
BRCA2 MUTATION CARRIERS | SURVIVAL | IMPACT | ULTRASOUND | ONCOLOGY | SUSCEPTIBILITY | FOLLOW-UP | RISK | RANDOMIZED CONTROLLED-TRIAL | AGE 40 | SCREENING-PROGRAM
Journal Article